| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $92.6M | -27.4% |
| R&D Expense | $26.8M | -36.3% |
| SG&A Expense | $58.4M | -20.8% |
| Operating Income | -$88.2M | +4.5% |
| Pre-tax Income | -$100.2M | -62.5% |
| Income Tax | -$3.9M | -26.7% |
| Net Income | -$37.4M | +36.2% |
| EPS (Basic) | -$0.98 | +38.4% |
| EPS (Diluted) | -$0.98 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.9M | -78.7% |
| Accounts Receivable | $32.0M | -53.8% |
| Current Assets | $59.4M | -67.5% |
| Total Assets | $198.1M | -47.3% |
| Current Liabilities | $61.0M | -67.7% |
| Long-term Debt | $41.2M | -46.9% |
| Total Liabilities | $184.6M | -45.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.7M | +67.6% |
| Capital Expenditures | $6.1M | +19.1% |
| Investing Cash Flow | -$1.6M | +97.1% |
| Financing Cash Flow | -$37.1M | -240.8% |
| Free Cash Flow | -$30.8M | +62.2% |
| +38.4% |
| Stockholders' Equity |
| $13.5M |
| -64.7% |